Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Switching from Abilify to Caplyta

Rationale for Gradual Cross-Titration

  • A gradual cross-titration over 2 weeks, tapering aripiprazole by approximately 10% per week while simultaneously initiating lumateperone at 42 mg daily, minimizes withdrawal symptoms and allows for receptor adaptation between these pharmacologically distinct agents, as recommended by The Lancet Psychiatry 1, 2, 3
  • The American Psychiatric Association implies that aripiprazole is a dopamine D2 partial agonist, while lumateperone is a full D2 antagonist, necessitating gradual transition to allow receptor adaptation and prevent treatment failure 3
  • Abrupt discontinuation of aripiprazole can lead to withdrawal symptoms, such as anxiety, insomnia, irritability, and mood changes, or symptom exacerbation in patients with schizophrenia, according to The Lancet Psychiatry 1, 2, 4

Specific Switching Protocol

  • The National Institute of Mental Health suggests reducing aripiprazole to 50% of current dose in week 1 and to 25% of original dose in week 2, while initiating lumateperone at 42 mg daily, to maintain antipsychotic coverage throughout the transition 4

Critical Monitoring Parameters

  • The American Academy of Psychiatry and the Law recommends monitoring closely for extrapyramidal symptoms, such as parkinsonism, akathisia, and restlessness, particularly during weeks 1-4 of the transition, as lumateperone has demonstrated low EPS risk 3

Common Pitfalls to Avoid

  • The Lancet Psychiatry advises against abruptly discontinuing aripiprazole, as its long half-life means plasma levels will persist, but sudden cessation increases withdrawal risk, and against using faster tapers than 10% per week for aripiprazole, as this increases the risk of withdrawal symptoms and symptom exacerbation 4

REFERENCES

3

Switching from Aripiprazole to Lurasidone [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Aripiprazole Dose Reduction Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025